15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Adapthealth Corp, 6 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $12.00 to $16.00, so the covering firms are broadly aligned. The average target of $14.33 sits 28% above the current $11.22. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 6 over recent months. On the fundamentals, the Street sees revenue growth near 7% this year and 6% next, consensus EPS building from about $0.34 next quarter toward $1.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy6100%
Hold00%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Adapthealth Corp.
As of Jul, 6 of 6 firms rate AHCO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AHCO EPS & revenue forecast
EPS · NEXT QUARTER
$0.34
Range $0.27 – $0.45 · 5 analysts · +46% YoY
Next period, 5 analysts expect Adapthealth Corp to earn $0.34 a share (range $0.27 – $0.45), versus $0.23 a year earlier. Full-year consensus is $0.89, growing to $1.17 the year after.
REVENUE · NEXT QUARTER
$886.2M
Range $852.8M – $902.4M · 5 analysts · +8% YoY
Revenue is expected to reach $886.2M (range $852.8M – $902.4M), +8.0% year-over-year. Full-year consensus is $3.5B, rising to $3.7B next year.
Top analysts covering Adapthealth Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AHCO.
#1
DM
David Macdonald
Truist Securities · Rank #67
Buy
$14.00+24.8% to target
Overall win rate
51%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Buy
$15.00+33.7% to target
Overall win rate
44%
+ Follow
#3
Richard Close
Canaccord Genuity
Buy
$16.00+42.6% to target
Coverage
—
+ Follow
#4
EC
Eric Coldwell
Baird
Buy
$15.00+33.7% to target
Coverage
—
+ Follow
#5
Kevin Caliendo
UBS
Buy
$14.00+24.8% to target
Coverage
—
+ Follow
AHCO stock forecast FAQ
What is AHCO's average 12-month price target?+
The 6 analysts with a live target average $14.33 for Adapthealth Corp over the next 12 months, ranging from a $16.00 high to a $12.00 low.
Is AHCO stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 6 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AHCO?+
The Street-high target is $16.00 (Canaccord Genuity), and the Street-low is $12.00 (Leerink Partners). The average of all 6 active targets is $14.33.
How many Wall Street analysts cover AHCO?+
6 analysts have an active rating on Adapthealth Corp, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering AHCO?+
Among analysts who currently cover AHCO, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Buy with a $14.00 target.
What is Adapthealth Corp's projected EPS for next quarter?+
The consensus estimate is $0.34 per share (range $0.27 – $0.45) across 5 analysts. Full-year EPS is projected at $0.89, rising to $1.17 the following year.
How much revenue is Adapthealth Corp expected to report next quarter?+
Consensus revenue is $886.2M (range $852.8M – $902.4M). Full-year revenue is projected at $3.5B, growing to $3.7B next year.
Have analysts been upgrading or downgrading AHCO lately?+
As of Jul, 6 of 6 firms rate AHCO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AHCO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
